Dr. Celia F Golden, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 85 Altura Way, Greenbrae, CA 94904 Phone: 415-461-1594 Fax: 415-439-1331 |
News Archive
Some countries in Africa "still rely on dichlorodiphenyltrichloroethane (DDT) for malaria vector control," therefore "[i]t is ... problematic that the U.N. Environment Programme (UNEP), without the consent of member states, and violating its own treaties, exerts relentless pressure to ban DDT globally," Richard Tren, director of Africa Fighting Malaria, and Richard Nchabi Kamwi, Nambia's minister of health and social services, write in a BMJ opinion piece.
Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.
Researchers at the University of Edinburgh have found that the protein invadolysin, which is essential for healthy cell division, is present in lipid droplets - the parts of cells used to store fat.
Like a stealth jet cloaks itself from radar, cancer cells cloak themselves within tumors by hiding behind a dense layer of cellular material known as stroma.
› Verified 3 days ago